申请人:Gilead Sciences, Inc.
公开号:US20140316132A1
公开(公告)日:2014-10-23
Provided are modulators of TLRs of Formula II:
pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
提供了TLR II的调节剂Formula II:其药学上可接受的盐,含有这种化合物的组合物以及包括给予这种化合物的治疗方法。